Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-72.83%Return on Equity
VS
Market
Sector
Industry
History
$ 9.43Close
$ 3.99 - $ 45.62 52-Week Range
Ticker Information
Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALIGOS THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALGS - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 101.87M | $ -74.18M | -72.83% |
| 3/31/2025 | $ 116.44M | $ -53.26M | -45.74% |
| 12/31/2024 | $ -28.97M | $ -131.21M | 0% |
| 9/30/2024 | $ 50.1M | $ -76.95M | -153.61% |
| 6/30/2024 | $ 67.23M | $ -75.73M | -112.65% |
| 3/31/2024 | $ 59.8M | $ -99.59M | -166.54% |
| 12/31/2023 | $ 92.08M | $ -87.68M | -95.22% |
| 9/30/2023 | $ 54.82M | $ -81.67M | -148.98% |
| 6/30/2023 | $ 69.64M | $ -82.25M | -118.12% |
| 3/31/2023 | $ 84.75M | $ -83.39M | -98.39% |
Key Performance Insights, Last 5 Years
- ALIGOS THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, ALIGOS THERAPEUTICS INC's average ROE has been -95.77%.
- The median ROE for ALIGOS THERAPEUTICS INC during this period was -92.26%
- ALIGOS THERAPEUTICS INC reached its highest ROE over the past 5 years at -45.74%.
- The lowest ROE recorded by ALIGOS THERAPEUTICS INC in the same timeframe -166.54%
ALIGOS THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ALIGOS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ -136.67M ]
(=) ROE [ 0% ] ALGS - Return on Equity, Last 5 years
-166.54%
Minimum
Mar 31, 2024
-45.74%
Maximum
Mar 31, 2025
-95.77%
Average
-92.26%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |